Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07217236 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Proactive Risk Evaluation for Cardiac Implantable Electronic Device Strategy Using AI-ECG

Study acronym: PRECISE-AI
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv3
  2. Primary and study completion dates: Sep 1, 2028 to Oct 31, 2026
    • Start date: Sep 1, 2025 to Nov 1, 2025
    • Study title shortened, about 8 words
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to learn whether an artificial intelligence-enhanced electrocardiogram (AI-ECG) strategy improves timely intervention of patients requiring cardiac implantable electronic devices (CIEDs), compared with standard clinical care.
Trial Details
NCT Number NCT07217236
Lead Sponsor National Defense Medical Center, Taiwan
Conditions
(from sponsor)		 Artificial Intelligence (AI), Cardiac Implantable Electrical Devices, Conduction Disorder of the Heart
Related terms Arrhythmias, Cardiac
Enrollment 11,492 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov